SG Carvalho, VHS Araujo, AM Dos Santos… - International journal of …, 2020 - Elsevier
To ensure success in the development and manufacturing of nanomedicines requires forces of an interdisciplinary team that combines medicine, engineering, chemistry, biology …
Background: Cancer remains a leading cause of death in companion animals. In human medicine, liposomes and nanoparticles have been extensively investigated as drug delivery …
OA Lenis-Rojas, C Roma-Rodrigues… - International Journal of …, 2022 - mdpi.com
Ruthenium (II) arene complexes exhibit promising chemotherapeutic properties. In this study, the effect of the counter anion in Ru (II) complexes was evaluated by analyzing the …
D Chirio, S Sapino, G Chindamo, E Peira, C Vercelli… - Pharmaceutics, 2022 - mdpi.com
Osteosarcoma (OSA) is the most frequently diagnosed primary malignant bone tumor in humans and dogs. In both species, standard chemotherapy can be limited by multidrug …
A Małek, B Taciak, K Sobczak, A Grzelak, M Wójcik… - Molecules, 2021 - mdpi.com
Osteosarcoma (OSA) is the most common malignant bone neoplasia in humans and dogs. In dogs, treatment consists of surgery in combination with chemotherapy (mostly carboplatin …
AR Fernandes, I Mendonça-Martins… - ACS Biomaterials …, 2020 - ACS Publications
CO-releasing molecules (CORMs) have been widely studied for their anti-inflammatory, antiapoptotic, and antiproliferative effects. CORM-3 is a water-soluble Ru-based metal …
Among pet species, mammary tumors are most commonly encountered in dogs. In the traditional treatment of mammary tumors in dogs; surgical operation, chemotherapy …
Metals have unique characteristics such as variable coordination modes, redox activity, and reactivity being indispensable for several biochemical processes in cells. Due to their …
S Mal, S Chakraborty, M Mahapatra… - Nanoscale …, 2024 - pubs.rsc.org
World Health Organization rate breast cancer as the most prevalent cancer despite its dominance in women. Surgery, hormonal treatment, chemo, and radiation therapy are the …